Systemic bevacizumab for refractory bleeding and transfusion-dependent anemia in Heyde syndrome

Heyde syndrome, the co-occurrence of aortic stenosis and bleeding gastrointestinal (GI) angiodysplasia, is managed with aortic valve replacement. However, severe bleeding and anemia can preclude safe use of the antiplatelet or anticoagulant therapy required for this intervention. We present a case o...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood advances 2021-10, Vol.5 (19), p.3850-3854
Hauptverfasser:	Song, Andrew B., Sakhuja, Rahul, Gracin, Nancy M., Weinger, Ronald, Kasthuri, Raj S., Al-Samkari, Hanny
Format:	Artikel
Sprache:	eng
Schlagworte:	Anemia - drug therapy Anemia - etiology Angiodysplasia - complications Angiodysplasia - drug therapy Aortic Valve Stenosis Bevacizumab - therapeutic use Exceptional Case Report Female Humans Vascular Endothelial Growth Factor A
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!